GIMS, Alkemi Growth Capital Plan to Unveil UP Startup Clinic

GIMS, Alkemi Growth Capital to Launch UP Startup Clinic with INR I000 Cr Healthcare Fund

GIMS, Alkemi Growth Capital to Launch UP Startup Clinic with INR I000 Cr Healthcare Fund

Designed as a hospital-based innovation platform, the Startup Clinic will provide support to healthcare startups with end-to-end guidance on clinical validation, regulatory compliance, investment readiness, and commercialisation.

The Government Institute of Medical Sciences (GIMS), Greater Noida, through its Centre for Medical Innovation (CMI), has announced plans to launch the Uttar Pradesh Startup Clinic in collaboration with Alkemi Growth Capital, an INR 1,000 crore healthcare-focused investment platform, and the MedTech Centre of Excellence (CoE) of the Software Technology Parks of India (STPI).

The initiative, being launched under the StartInUP Initiative of the Department of IT & Electronics, Government of Uttar Pradesh, aims to strengthen the state's healthcare innovation ecosystem by supporting startups from concept development to commercialisation.

Designed as a hospital-based innovation platform, the Startup Clinic will provide support to healthcare startups with end-to-end guidance on clinical validation, regulatory compliance, investment readiness and commercialization.

The programme is being organised under the guidance of Alok Kumar, IAS, Principal Secretary, Department of IT & Electronics, Government of Uttar Pradesh, to create a stronger pipeline of investment-ready healthcare startups from the state.

Speaking on the initiative, Dr. (Brig.) Rakesh Gupta, Director of GIMS Greater Noida, described the Startup Clinic as an important step towards helping entrepreneurs develop globally competitive healthcare technologies.

He added the initiative would provide startups with access to research, clinical expertise, innovation support and leading institutional investors, creating an ecosystem where healthcare innovation and entrepreneurship can thrive together.

A key highlight of the inaugural Startup Clinic will be the participation of Alkemi Growth Capital, a SEBI-registered Category II Alternative Investment Fund (AIF) that manages an investment platform of nearly INR 1,000 crore dedicated to the healthcare sector.

According to the announcement, Alkemi Growth Capital will work with GIMS through its Centre for Medical Innovation (CMI-GIMS) to support startups across different stages of innovation.

Known for backing high-growth companies in Healthcare, MedTech, HealthTech, Medical Devices, Diagnostics, Biotechnology, Artificial Intelligence, Life Sciences and Digital Health, Alkemi typically invests between INR 20 crore and INR 25 crore in companies that have demonstrated strong market potential and are ready for expansion.

The collaboration is expected to create opportunities for entrepreneurs to interact with healthcare professionals, receive feedback on product development, and explore funding pathways.

The founders will have an opportunity to interact directly with Alkemi’s investment team to understand what institutional investors expect before making funding decisions.

Discussions will focus on areas such as clinical validation, regulatory preparedness, governance, commercial scalability, and investment readiness.

The Uttar Pradesh Startup Clinic is expected to serve as a collaborative platform connecting startups with hospitals, regulators, investors, academic institutions, and industry partners.

Through this initiative, GIMS aims to accelerate healthcare innovation and position Uttar Pradesh as a leading destination for medical technology development, healthcare entrepreneurship, and institutional investment.

Commenting on the collaboration, Dr. Rahul Singh, CEO of the Centre for Medical Innovation (CMI), said bringing Alkemi Growth Capital’s INR 1,000 crore healthcare investment platform to Uttar Pradesh marks a major milestone for the state’s innovation ecosystem.

According to him, the Startup Clinic will enable founders to understand the expectations of late-stage investors while leveraging GIMS’ strengths in clinical validation, regulatory mentoring, incubation and clinical trial support, ultimately helping startups build globally scalable healthcare enterprises.

Stay tuned for more such updates on Digital Health News

Follow us

More Articles By This Author


Show All

Sign In / Sign up